Clinical Trials | May 23, 2026
Eli lilly’s retatrutide delivers up to 30% weight loss in phase 3 trial
Clears major obesity endpoints at 80 weeks
Clears major obesity endpoints at 80 weeks
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
More than 450 public and private health technology solutions have integrated with the Ayushman Bharat Digital Mission ecosystem
All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks
The competition received over 42 entries from nursing colleges across Maharashtra
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
The therapy is suited for patients with severe valve leakage who face elevated surgical risk due to advanced age, frailty, or multiple medical complications
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
The country’s strength lies not just in technology availability but in adoption behaviour
Subscribe To Our Newsletter & Stay Updated
